Skip to main content

Table 3 Overall reporting of outcome measures

From: Problems with the outcome measures in randomized controlled trials of traditional Chinese medicine in treating chronic heart failure caused by coronary heart disease: a systematic review

Outcome measures

Included trials, n (%)a

Cochrane systematic reviews, n (%)b

All-cause mortality

0 (0)

16 (100)

Mortality

4 (12.90)

/

HF hospitalization

0 (0)

11 (68.75)

Rehospitalization

4 (12.90)

/

ADRs

17 (54.84)

10 (62.50)

QoL

0 (0)

7 (43.75)

Cardiovascular events

0 (0)

6 (37.50)

All-cause hospitalization

0 (0)

5 (31.25)

Cardiovascular mortality

0 (0)

5 (31.25)

LVEF

17 (54.84)

4 (25)

Classification of cardiac function

0 (0)

2 (12.50)

Efficacy of cardiac function

26 (83.87)

0 (0)

BNP

5 (16.13)

1 (6.25)

6MWD

14 (45.16)

0 (0)

  1. Notes: HF Heart failure, ADRs Adverse drug reactions, QoL Quality of life, LVEF Left ventricular ejection fraction, BNP Brain natriuretic peptide, 6MWD 6 min’ walk distance; areporting rate of included trials = n/31, bof Cochrane systematic reviews = n/16